Firm announces new sector heads

17 Mar 2017

International law firm Simmons & Simmons has announced new partners to lead its sector groups for financial institutions and life sciences.

Financial services partner Charlotte Stalin will succeed Jonathan Hammond as the firm’s head of financial institutions on 01 May 2017. Charlotte is based in London and specialises in UK and European regulatory matters, advising financial institutions on key regulatory developments, including MiFID2 and Brexit. She joined the firm as a partner in 2006 and was named “Legal Innovator of the Year” at the FT Innovative Lawyers Awards in October 2016.

Financial institutions is the largest of the firm’s sector groups, working with 30 of the world’s top 50 banks in the last year alone. The position is currently held by Jonathan Hammond, who has been in the role since 2011. He will continue to lead the firm’s financial markets practice and chair the firm’s Innovation Group.

Dispute resolution partner Alexandre Regniault will succeed Jacques-Antoine Robert as the firm’s head of life sciences also on 01 May. Alexandre joined the firm in 2002 and became a partner in 2008. Alexandre is based in Paris and specialises in dispute resolution and regulatory advice, for pharmaceutical, medical devices and biotech companies, and their insurers. He has developed specific expertise in legal and strategic advice on health products market access, from clinical trials to health technology assessment, pricing and reimbursement. Alexandre is experienced in crisis management and frequently liaises with the French regulatory authorities on behalf of industry players.

The position is currently held by Jacques-Antoine Robert, who has fulfilled this role since 2009. Jacques-Antoine is recognised by Chambers as a Star Individual for Pharma/Life Sciences and will continue to fulfil management roles within the firm.

The firm is recognised worldwide as a pre-eminent law firm for life sciences. The international team advises many of the world’s leading pharma, biotech, medical device and healthcare companies, including: global pharmaceutical companies, fast growing biotechs, leading medical devices manufacturers, private and public healthcare establishments and service providers and household names in consumer healthcare.

Charlotte says: “It is an exciting time to be taking on this role. Simmons & Simmons is embedded in the international financial and regulatory community and committed to innovation, and I look forward to building on Jonathan’s work in the sector. In particular, I welcome the opportunities we will have to continue evolving our services in order to meet our clients’ business requirements with tailored, commercial and cost-effective advice.’’

Alexandre commented: “I am very pleased to be taking on this role and look forward to continuing the development of the firm’s award winning life sciences practice around our international network. I welcome the chance to work with clients and colleagues as we work together to continue to address the challenges and opportunities that arise in this exciting sector.”

Speaking on the appointments, managing partner, Jeremy Hoyland observed: “The firm’s sector strategy lies at the heart of our business: by focusing on a small number of key sectors, we seek to deliver the best possible service to clients working within those industries. I would like to thank Jonathan and Jacque-Antoine for their leadership of our financial institutions and life sciences sectors, and I look forward to working with Charlotte and Alexandre in their new roles.’’

Follow Us

www.elexica.com

LinkedIn | Twitter